EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

CRISPR screening identifies PRMT1 as a key pro-ferroptotic gene via a two-layer regulatory mechanism

Xin Zhang, Yajun Duan, Su Li, Zhenyuan Zhang, Linyuan Peng, Xiaoyu Ma, Tianzhi Wang, Siliang Xiang, Guo Chen, Danyang Zhou, Desheng Lu, Minxian Qian und 1 weitere

Cell Reports · 2024-09 · 43 (9) · 114662

DOI: 10.1016/j.celrep.2024.114662 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2024-09. Verfasst von Xin Zhang und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Medicines, Department of Life Science and Technology, China Pharmaceutical University, Nanjing 211198, China; Guangdo…. Hauptthemen laut MEDLINE: Protein-Arginine N-Methyltransferases, Ferroptosis. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ferroptosis is a form of nonapoptotic cell death characterized by iron-dependent peroxidation of polyunsaturated phospholipids. However, much remains unknown about the regulators of ferroptosis. Here, using CRISPR-Cas9-mediated genetic screening, we identify protein arginine methyltransferase 1 (PRMT1) as a crucial promoter of ferroptosis. We find that PRMT1 decreases the expression of solute carrier family 7 member 11 (SLC7A11) to limit the abundance of intracellular glutathione (GSH). Moreover, we show that PRMT1 interacts with ferroptosis suppressor protein 1 (FSP1), a GSH-independent ferroptosis suppressor, to inhibit the membrane localization and enzymatic activity of FSP1 through arginine dimethylation at R316, thus reducing CoQ10H2 content and inducing ferroptosis sensitivity. Importantly, genetic depletion or pharmacological inhibition of PRMT1 in mice prevents ferroptotic events in the liver and improves the overall survival under concanavalin A (ConA) exposure. Hence, our findings suggest that PRMT1 is a key regulator of ferroptosis and a potential target for antiferroptosis therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein-Arginine N-MethyltransferasesFerroptosisAnimalsHumansMiceCRISPR-Cas SystemsMice, Inbred C57BLGlutathioneAmino Acid Transport System y+MaleLiverRepressor ProteinsHEK293 Cells

Stichwörter der Autor:innen

ADMACP: ImmunologyCP: MetabolismFSP1PRMT1SLC7A11acute liver injuryferroptosis

Substanzen

Protein-Arginine N-MethyltransferasesPRMT1 protein, humanPrmt1 protein, mouseGlutathioneAmino Acid Transport System y+Repressor Proteins

Autor:innen und Institutionen

  • State Key Laboratory of Natural Medicines, Department of Life Science and Technology, China Pharmaceutical University, Nanjing 211198, China; Guangdong Provincial Key Laboratory of Regional Immunity and Diseases, Cancer…
  • State Key Laboratory of Natural Medicines, Department of Life Science and Technology, China Pharmaceutical University, Nanjing 211198, China.
  • School of Biopharmacy, China Pharmaceutical University, Nanjing 211198, China.
  • Department of Respiratory, Nanjing First Hospital, China Pharmaceutical University, Nanjing 210012, China.
  • Guangdong Provincial Key Laboratory of Regional Immunity and Diseases, Cancer Research Center, Department of Pharmacology, Shenzhen University Medical School, Shenzhen 518055, China. Electronic address: delu@szu.edu.cn.
  • State Key Laboratory of Natural Medicines, Department of Life Science and Technology, China Pharmaceutical University, Nanjing 211198, China. Electronic address: qmx@cpu.edu.cn.

Zitieren

APA

Zhang, X., Duan, Y., Li, S., Zhang, Z., Peng, L., Ma, X., Wang, T., Xiang, S., Chen, G., Zhou, D., Lu, D., Qian, M., & Wang, Z. (2024). CRISPR screening identifies PRMT1 as a key pro-ferroptotic gene via a two-layer regulatory mechanism. Cell Reports, 43(9), 114662. https://doi.org/10.1016/j.celrep.2024.114662

Vancouver

Zhang X, Duan Y, Li S, Zhang Z, Peng L, Ma X, et al. CRISPR screening identifies PRMT1 as a key pro-ferroptotic gene via a two-layer regulatory mechanism. Cell Reports. 2024;43(9):114662. doi:10.1016/j.celrep.2024.114662

BibTeX
@article{Zhang2024,
  author = {Zhang, Xin and Duan, Yajun and Li, Su and Zhang, Zhenyuan and Peng, Linyuan and Ma, Xiaoyu and Wang, Tianzhi and Xiang, Siliang and Chen, Guo and Zhou, Danyang and Lu, Desheng and Qian, Minxian and Wang, Zhongyuan},
  title = {CRISPR screening identifies PRMT1 as a key pro-ferroptotic gene via a two-layer regulatory mechanism},
  journal = {Cell Reports},
  year = {2024},
  volume = {43},
  number = {9},
  pages = {114662},
  doi = {10.1016/j.celrep.2024.114662}
}
Kostenlos starten →